8,240 Clinical Drug Overviews
BIO-TROPIN
Comprehensive clinical and safety monograph for BIO-TROPIN (BIO-TROPIN).
INJECTION
BIORPHEN
Comprehensive clinical and safety monograph for BIORPHEN (BIORPHEN).
INTRAVENOUS
BIOSCRUB
Comprehensive clinical and safety monograph for BIOSCRUB (BIOSCRUB).
TOPICAL
BIPHETAMINE 12.5
Comprehensive clinical and safety monograph for BIPHETAMINE 12.5 (BIPHETAMINE 12.5).
ORAL
BIPHETAMINE 20
Comprehensive clinical and safety monograph for BIPHETAMINE 20 (BIPHETAMINE 20).
BIPHETAMINE 7.5
Comprehensive clinical and safety monograph for BIPHETAMINE 7.5 (BIPHETAMINE 7.5).
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
Antacids and calcium supplements decrease absorption Can cause photosensitivity and tooth discoloration in children.
Tetracycline Antibiotic
BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
BISOPROLOL FUMARATE
Calcium channel blockers like verapamil may cause bradycardia and heart failure Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.
Beta-Blocker
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.
Thiazide Diuretic
BIVALIRUDIN
Comprehensive clinical and safety monograph for BIVALIRUDIN (BIVALIRUDIN).
INTRAVENOUS, INJECTION
BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
No significant drug interactions Can cause hypernatremia and fluid overload.
Electrolyte
BIZENGRI
Comprehensive clinical and safety monograph for BIZENGRI (BIZENGRI).
SOLUTION
BKEMV
Comprehensive clinical and safety monograph for BKEMV (BKEMV).
BLENOXANE
Comprehensive clinical and safety monograph for BLENOXANE (BLENOXANE).
BLENREP
Comprehensive clinical and safety monograph for BLENREP (BLENREP).
BLEOMYCIN SULFATE
Comprehensive clinical and safety monograph for BLEOMYCIN SULFATE (BLEOMYCIN SULFATE).
BLEPH-10
Comprehensive clinical and safety monograph for BLEPH-10 (BLEPH-10).
OPHTHALMIC
BLEPH-30
Comprehensive clinical and safety monograph for BLEPH-30 (BLEPH-30).
BLEPHAMIDE
Comprehensive clinical and safety monograph for BLEPHAMIDE (BLEPHAMIDE).
BLEPHAMIDE S.O.P.
Comprehensive clinical and safety monograph for BLEPHAMIDE S.O.P. (BLEPHAMIDE S.O.P.).
BLINCYTO
Comprehensive clinical and safety monograph for BLINCYTO (BLINCYTO).
BLISOVI 24 FE
Comprehensive clinical and safety monograph for BLISOVI 24 FE (BLISOVI 24 FE).
BLISOVI FE 1.5/30
Comprehensive clinical and safety monograph for BLISOVI FE 1.5/30 (BLISOVI FE 1.5/30).
ORAL-28
BLISOVI FE 1/20
Comprehensive clinical and safety monograph for BLISOVI FE 1/20 (BLISOVI FE 1/20).
BLOCADREN
Comprehensive clinical and safety monograph for BLOCADREN (BLOCADREN).
BLOXIVERZ
Comprehensive clinical and safety monograph for BLOXIVERZ (BLOXIVERZ).
BLUDIGO
Comprehensive clinical and safety monograph for BLUDIGO (BLUDIGO).
BLUJEPA
Comprehensive clinical and safety monograph for BLUJEPA (BLUJEPA).
BOMYNTRA
Comprehensive clinical and safety monograph for BOMYNTRA (BOMYNTRA).
Therapeutic Agent
BONCRESA
Comprehensive clinical and safety monograph for BONCRESA (BONCRESA).
SUBCUTANEOUS
BONDLIDO
Comprehensive clinical and safety monograph for BONDLIDO (BONDLIDO).
BONIVA
Comprehensive clinical and safety monograph for BONIVA (BONIVA).
INTRAVENOUS, ORAL
BONJESTA
Comprehensive clinical and safety monograph for BONJESTA (BONJESTA).
BONSITY
Comprehensive clinical and safety monograph for BONSITY (BONSITY).
BONTRIL
Comprehensive clinical and safety monograph for BONTRIL (BONTRIL).
BONTRIL PDM
Comprehensive clinical and safety monograph for BONTRIL PDM (BONTRIL PDM).
BOROFAIR
Comprehensive clinical and safety monograph for BOROFAIR (BOROFAIR).
OTIC
BORTEZOMIB
Strong CYP3A4 inducers may decrease efficacy Peripheral neuropathy is a common and sometimes severe toxicity requiring dose adjustment.
Proteasome Inhibitor
BOSAYA
Comprehensive clinical and safety monograph for BOSAYA (BOSAYA).
BOSENTAN
Strong CYP3A4 inducers like rifampin decrease levels and inhibitors like ketoconazole increase levels Requires monthly monitoring of liver enzymes due to risk of hepatotoxicity.
Endothelin Receptor Antagonist
BOSULIF
Comprehensive clinical and safety monograph for BOSULIF (BOSULIF).
BOSUTINIB
Comprehensive clinical and safety monograph for BOSUTINIB (BOSUTINIB).
FILM COATED
BOSUTINIB MONOHYDRATE
Comprehensive clinical and safety monograph for BOSUTINIB MONOHYDRATE (BOSUTINIB MONOHYDRATE).
BOTOX
Comprehensive clinical and safety monograph for BOTOX (BOTOX).
SINGLE-USE
BOTOX COSMETIC
Comprehensive clinical and safety monograph for BOTOX COSMETIC (BOTOX COSMETIC).
BRAFTOVI
Comprehensive clinical and safety monograph for BRAFTOVI (BRAFTOVI).
BRANCHAMIN 4%
Comprehensive clinical and safety monograph for BRANCHAMIN 4% (BRANCHAMIN 4%).
BRANCHAMIN 4% IN PLASTIC CONTAINER
Comprehensive clinical and safety monograph for BRANCHAMIN 4% IN PLASTIC CONTAINER (BRANCHAMIN 4% IN PLASTIC CONTAINER).
BRAVELLE
Comprehensive clinical and safety monograph for BRAVELLE (BRAVELLE).
Subcutaneous, INTRAMUSCULAR, SUBCUTANEOUS
Showing 901 - 950 of 8245
